BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1448779)

  • 1. Mutations in severe, type III von Willebrand's disease in the Dutch population: candidate missense and nonsense mutations associated with reduced levels of von Willebrand factor messenger RNA.
    Eikenboom JC; Ploos van Amstel HK; Reitsma PH; Briët E
    Thromb Haemost; 1992 Oct; 68(4):448-54. PubMed ID: 1448779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New mutations in exon 28 of the von Willebrand factor gene detected in patients with different types of von Willebrand's disease.
    Casaña P; Martínez F; Haya S; Tavares A; Aznar JA
    Haematologica; 2001 Apr; 86(4):414-9. PubMed ID: 11325649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the von Willebrand factor gene (VWF) in von Willebrand disease type III patients from 24 families of Swedish and Finnish origin.
    Zhang ZP; Blombäck M; Egberg N; Falk G; Anvret M
    Genomics; 1994 May; 21(1):188-93. PubMed ID: 8088787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three distinct candidate point mutations of the von Willebrand factor gene in four patients with type IIA von Willebrand disease.
    Sugiura I; Matsushita T; Tanimoto M; Takahashi I; Yamazaki T; Yamamoto K; Takamatsu J; Kamiya T; Saito H
    Thromb Haemost; 1992 Jun; 67(6):612-7. PubMed ID: 1380739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression studies of missense mutations p.D141Y, p.C275S located in the propeptide of von Willebrand factor in patients with type 3 von Willebrand disease.
    Baronciani L; Federici AB; Cozzi G; La Marca S; Punzo M; Rubini V; Canciani MT; Mannucci PM
    Haemophilia; 2008 May; 14(3):549-55. PubMed ID: 18328061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding von Willebrand's disease from gene defects to the patients.
    Zhang Z; Blombäck M; Anvret M
    J Intern Med Suppl; 1997; 740():115-9. PubMed ID: 9350192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in von Willebrand factor multimerization domains are not a common cause of classical type 1 von Willebrand disease.
    Keeney S; Cumming A; Hay C
    Thromb Haemost; 1999 Nov; 82(5):1446-50. PubMed ID: 10595636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic defects in von Willebrand disease type 3 in Indian and Greek patients.
    Gupta PK; Saxena R; Adamtziki E; Budde U; Oyen F; Obser T; Schneppenheim R
    Blood Cells Mol Dis; 2008; 41(2):219-22. PubMed ID: 18485763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
    Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic linkage of two intragenic restriction fragment length polymorphisms with von Willebrand's disease type IIA. Evidence for a defect in the von Willebrand factor gene.
    Verweij CL; Quadt R; Briët E; Dubbeldam K; van Ommen GB; Pannekoek H
    J Clin Invest; 1988 Apr; 81(4):1116-21. PubMed ID: 2895123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A von Willebrand's factor genomic nucleotide variant and polymerase chain reaction diagnostic test associated with inheritable type-2 von Willebrand's disease in a line of german shorthaired pointer dogs.
    Kramer JW; Venta PJ; Klein SR; Cao Y; Schall WD; Yuzbasiyan-Gurkan V
    Vet Pathol; 2004 May; 41(3):221-8. PubMed ID: 15133170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of mutations in the canine von Willebrand factor gene associated with type III von Willebrand disease.
    Rieger M; Schwarz HP; Turecek PL; Dorner F; van Mourik JA; Mannhalter C
    Thromb Haemost; 1998 Aug; 80(2):332-7. PubMed ID: 9716162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.
    Michiels JJ; Gadisseur A; Vangenegten I; Schroyens W; Berneman Z
    Acta Haematol; 2009; 121(2-3):119-27. PubMed ID: 19506358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic mutations in von Willebrand disease identified by DHPLC and DNA sequence analysis.
    Kakela JK; Friedman KD; Haberichter SL; Buchholz NP; Christopherson PA; Kroner PA; Gill JC; Montgomery RR; Bellissimo DB
    Mol Genet Metab; 2006 Mar; 87(3):262-71. PubMed ID: 16321553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 2N von Willebrand disease: rapid genetic diagnosis of G2811A (R854Q), C2696T (R816W), T2701A (H817Q) and G2823T (C858F)--detection of a novel candidate type 2N mutation: C2810T (R854W).
    Bowen DJ; Standen GR; Mazurier C; Gaucher C; Cumming A; Keeney S; Bidwell J
    Thromb Haemost; 1998 Jul; 80(1):32-6. PubMed ID: 9684781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetics of von Willebrand disease.
    Mazurier C; Ribba AS; Gaucher C; Meyer D
    Ann Genet; 1998; 41(1):34-43. PubMed ID: 9599650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A common splice site mutation is shared by two families with different type 2N von Willebrand disease mutations.
    Nesbitt IM; Hampton KK; Preston FE; Peake IR; Goodeve AC
    Thromb Haemost; 1999 Sep; 82(3):1061-4. PubMed ID: 10494764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L1503R is a member of group I mutation and has dominant-negative effect on secretion of full-length VWF multimers: an analysis of two patients with type 2A von Willebrand disease.
    Kashiwagi T; Matsushita T; Ito Y; Hirashima K; Sanda N; Fujimori Y; Yamada T; Okumura K; Takagi A; Murate T; Katsumi A; Takamatsu J; Yamamoto K; Naoe T; Kojima T
    Haemophilia; 2008 May; 14(3):556-63. PubMed ID: 18397285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.